MT

Minal Thukaram Korade

Active Director Director DIN 11132879
DIN 11132879 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Minal Thukaram Korade

Data last updated:

Minal Thukaram Korade is a Director at Arogyasadan Medical Private Limited (since 2025).

DIN 11132879
Primary Designation Director
First Appointment 30 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arogyasadan Medical Private Limited U86201PN2025PTC242560
Director30 May 20252025Active

Directorship timeline

Open interactive timeline →
Arogyasadan Medical Private Limited
Premium access

Shareholding and investment profile for Minal Thukaram Korade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Minal Thukaram Korade

Minal Thukaram Korade currently holds 1 directorship: Arogyasadan Medical Private Limited (Director, since 30 May 2025).

Minal Thukaram Korade was first appointed on 30 May 2025 as Director at Arogyasadan Medical Private Limited.

The current boards of Minal Thukaram Korade's companies include Aarti Dhananjay Ware (Arogyasadan Medical Private Limited), Ashwini Namdeo Satpute (Arogyasadan Medical Private Limited), Gayatri Manohar Badarkhe (Arogyasadan Medical Private Limited), Nikhil Dnyandev Satpute (Arogyasadan Medical Private Limited), Sneha Ramesh Bharad (Arogyasadan Medical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available